Document Detail


Gene knockout of the KCNJ8-encoded Kir6.1 K(ATP) channel imparts fatal susceptibility to endotoxemia.
MedLine Citation:
PMID:  17077304     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Sepsis, the systemic inflammatory response to infection, imposes a high demand for bodily adaptation, with the cardiovascular response a key determinant of outcome. The homeostatic elements that secure cardiac tolerance in the setting of the sepsis syndrome are poorly understood. Here, in a model of acute septic shock induced by endotoxin challenge with Escherichia coli lipopolysaccharide (LPS), knockout of the KCNJ8 gene encoding the vascular Kir6.1 K(ATP) channel pore predisposed to an early and profound survival disadvantage. The exaggerated susceptibility provoked by disruption of this stress-responsive sensor of cellular metabolism was linked to progressive deterioration in cardiac activity, ischemic myocardial damage, and contractile dysfunction. Deletion of KCNJ8 blunted the responsiveness of coronary vessels to cytokine- or metabolic-mediated vasodilation necessary to support myocardial perfusion in the wild-type (WT), creating a deficit in adaptive response in the Kir6.1 knockout. Application of a K(ATP) channel opener drug improved survival in the endotoxic WT but had no effect in the Kir6.1 knockout. Restoration of the dilatory capacity of coronary vessels was required to rescue the Kir6.1 knockout phenotype and reverse survival disadvantage in lethal endotoxemia. Thus, the Kir6.1-containing K(ATP) channel, by coupling vasoreactivity with metabolic demand, provides a vital feedback element for cardiovascular tolerance in endotoxic shock.
Authors:
Garvan C Kane; Chen-Fuh Lam; Fearghas O'Cochlain; Denice M Hodgson; Santiago Reyes; Xiao-Ke Liu; Takashi Miki; Susumu Seino; Zvonimir S Katusic; Andre Terzic
Related Documents :
16923414 - A randomized multicenter clinical study to evaluate the safety and efficacy of the tand...
626124 - Progressive nature of myocardial injury in selected patients with cardiogenic shock.
18655944 - The use of vasopressors and inotropes in the emergency medical treatment of shock.
8483194 - Combined severe myocardial and pulmonary contusion: early diagnosis with transesophagea...
11499734 - Cardiac nitric oxide production due to angiotensin-converting enzyme inhibition decreas...
21273554 - A peptide mimetic of the connexin43 carboxyl terminus reduces gap junction remodeling a...
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  FASEB journal : official publication of the Federation of American Societies for Experimental Biology     Volume:  20     ISSN:  1530-6860     ISO Abbreviation:  FASEB J.     Publication Date:  2006 Nov 
Date Detail:
Created Date:  2006-11-01     Completed Date:  2006-11-27     Revised Date:  2012-02-15    
Medline Journal Info:
Nlm Unique ID:  8804484     Medline TA:  FASEB J     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2271-80     Citation Subset:  IM    
Affiliation:
Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Aorta / physiopathology
Coronary Circulation
Endotoxemia / genetics*,  pathology,  physiopathology
Genetic Predisposition to Disease
Hemodynamics
KATP Channels
Lipopolysaccharides / toxicity
Mice
Mice, Inbred C57BL
Mice, Knockout
Myocardium / pathology
Potassium Channels, Inwardly Rectifying / deficiency*,  genetics*
Telemetry
Vasoconstriction
Vasodilation
Chemical
Reg. No./Substance:
0/KATP Channels; 0/Lipopolysaccharides; 0/Potassium Channels, Inwardly Rectifying; 0/uK-ATP-1 potassium channel

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Human ACE and bradykinin B2 receptors form a complex at the plasma membrane.
Next Document:  Cytocidal effects of atheromatous plaque components: the death zone revisited.